金徽酒(603919.SH):海南豫珠要约收购期满 明日停牌一天
格隆汇10月15日丨金徽酒(603919.SH)公布,公司于2020年9月14日公告了《金徽酒股份有限公司要约收购报告书》,海南豫珠企业管理有限公司向除上海豫园旅游商城(集团)股份有限公司已持有的公司股份以外的4058.08万股已上市无限售条件流通股进行部分要约收购,要约收购期限为2020年9月16日至2020年10月15日。
目前,要约收购期限届满,因要约收购结果尚需进一步确认,根据《上海证券交易所股票上市规则》有关规定,经申请,公司股票于2020年10月16日停牌一天,并将在要约收购结果公告当天复牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.